SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford Health Plan (OXHP)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: men mailman who wrote (244)11/22/1997 12:23:00 PM
From: wolfdog2   of 2068
 
Thanks for posting the information about the article.

It's interesting to note also that even with the recent debacle that Value Line, which tends to be conservative, imho, rates OXHP as a "3", which if I recall means it will perform with the market. The significance of this is that if VL thought the problems would affect the viability of the company they would probably have dropped the rating down to a 4 or 5.

It is my impression, being both a provider and living in one of the areas where OXHP is strong, that OXHP has a good reputation both among providers and patients. This is certainly a winning combination.

I view the lawsuits as being a nuisance and nothing more. I think that once tax selling is out of the way, OXHP (barring any further bad news) will start to trend up. Anyone interested should take a look at SCHL, which got bombed out of the sky when an unexpected problem emerged. The stock dove to ~20 and is now trading in the mid 30's.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext